4938
M. A. P. Martins et al. / Tetrahedron Letters 45 (2004) 4935–4938
1
3
Pacholski, I. L.; Faoro, D.; Bonacorso, H. G.; Martins,
M. A. P. Synth. Commun. 2001, 31, 2855.
1. Zanatta, N.; Barichello, R.; Bonacorso, H. G.; Martins,
M. A. P. Synthesis 1999, 5, 765.
2. Bonacorso, H. G.; Bittencourt, S. R. T.; Lourega, R. V.;
Flores, A. F. C.; Zanatta, N.; Martins, M. A. P. Synthesis
C NMR (CDCl
(C3), 64.0 (C4).
Compound 3a, C10
3
, 100 MHz) d 164.3 (C2), 89.7 (C1), 71.7
2
2
H
6
Cl
2
O (M. wt 213.06); bp 85 ꢁC/
þ
2.3 mbar; CG-MS (EI 70 eV) m=z (%): 212 (M , 5), 129
(100), 101 (23), 77 (57), 51 (8);
1
H NMR (CDCl
(s, 1H, H1);
3
, 400 MHz) d 7.59–7.17 (m, 5H, Ph), 5.85
2000, 1.
1
3
2
3. (a) Bonacorso, H. G.; Bittencourt, S. R. T.; Wastowski, A.
D.; Wentz, A. P.; Zanatta, N.; Martins, M. A. P.
Tetrahedron Lett. 1996, 37, 9155; (b) Bonacorso, H. G.;
Bittencourt, S. R. T.; Wastowski, A. D.; Wentz, A. P.;
Zanatta, N.; Martins, M. A. P. J. Heterocycl. Chem. 1999,
C NMR (CDCl
3
, 100 MHz) d 173.8 (C2), 133.5, 132.0,
128.7, 118.8 (Ph), 97.9 (C3), 83.4 (C4), 70.0 (C1).
Compound 4a, C10 (M. wt 216.15); oil; CG-MS
7 3 2
H F O
þ
(EI 70 eV) m=z (%): 216 (M , 32), 187 (95), 129 (100), 108
(17), 77 (10);
1
36, 45.
H NMR (CDCl
3
3
, 400 MHz) d 7.45–7.22 (m, 5H, Ph);
1
2
4. Ziegler, G. R.; Welch, C. A.; Orzech, C. E.; Kikkawa, S.;
Miller, S. I. J. Am. Chem. Soc. 1963, 85, 1648.
5. Andrew, R. J.; Mellor, J. M. Tetrahedron 2000, 56, 7261.
6. (a) Ishii, S.; Yagi, K.; Umehara, T.; Kudo, M.; Nawa-
maki, T.; Watanabe, S. Japan Kokai, Tokkyo Koho JP 02,
C NMR (CDCl , 100 MHz) d 133.7–128.1 (Ph); 123.8
3
1
(C1, q, JC–F ¼ 289 Hz), 84.0 (C4), 82.1 (C3), 65.2 (C2, q,
2
2
2
J
Compound 4b, C
C–F ¼ 37 Hz).
4
H
3
F
3
O
2
(M. wt 140.05); oil; CG-MS (EI
þ
70 eV) m=z (%): 140 (M , 2), 136 (14), 108 (5), 55 (100);
1
129, 171. Chem. Abstr. 1990, 113, 17201a; (b) Buntain, I.
G.; Hatton, L. R.; Hawkins, D. W.; Pearson, C. J.;
Roberts, D. A. Eur. Pat. Appl. EP 295, 117. Chem. Abstr.
H NMR (CDCl
3
3
, 400 MHz) d 2.63 (s, 1H, H4);
1
1
C
NMR (CDCl 100 MHz) 126.8 (C1, q,
3
,
d
2
J
C–F ¼ 285 Hz), 77.3 (C3), 75.9 (C2, q,
JC–F ¼ 26 Hz),
1
990, 112, 35845n; (c) Moser, H.; Bohner, B.; Foery, W.
Eur. Pat. Appl. EP 268, 554; Chem. Abstr. 1988, 110,
3879; (d) Ishii, T.; Shimotori, H.; Tanaka, Y.; Ishikawa,
65.8 (C4).
Compound 4c, C
9
H
13
F
3
O
2
(M. wt 210.19); oil; CG-MS
þ
2
(EI 70 eV) m=z (%): 210 (M , 2), 153 (65), 141 (75), 71
(100);
K. Japan Kokai, Tokkyo Koho JP 01, 168, 675. Chem.
Abstr. 1989, 112, 35854; (e) Okada, I.; Yoshida, K.;
Sekine, K. Japan Kokai, Tokkyo Koho, JP 02, 292, 263.
Chem. Abstr. 1990, 114, 185497; (f) Sohn, E.; Handle, R.;
Mildenberger, H.; Buerstell, H.; Bauer, K.; Bieringer, H.
German Patent 3, 633, 840. Chem. Abstr. 1988, 110, 8202.
7. (a) Casida, J. E.; Pulman, D. A. In Advances in the
Chemistry of Insect Control III; Briggs, G. G., Ed.; Proc
1
3
H NMR (CDCl , 400 MHz) d 2.42 (t, 2H, H5), 2.19 (m,
2H, H6), 1.78 (m, 2H, H7), 1.43 (m, 2H, H8), 0.84 (t, 3H,
H9);
1
1
2
3
C
NMR (CDCl
3
,
100 MHz)
d
124.1 (C1, q,
J
J
C–F ¼ 285 Hz), 105.1 (C3), 91.6 (C4), 65.8 (C2, q,
2
C–F ¼ 26 Hz), 30.8 (C5), 26.7 (C6), 21.9 (C7), 18.4 (C8),
13.5 (C9).
3
rd Int. Symp. Adv. Chem. of Insect Control, Spec. Publ.
9 2
Compound 5a, C13H O N (M. wt 211.21); oil; CG-MS (EI
þ
1994, 147, p 36; (b) Bloomquist, J. R. In Biochemical Sites
70 eV) m=z (%): 211 (M , 33), 129 (100), 101 (9), 75 (19);
1
of Insecticide Action and Resistance; Ishaaya, I., Ed.;
Springer: Berlin, 2001; p 17; (c) Colliot, F.; Kukorowski,
K. A.; Hawkins, D. W.; Roberts, D. A. In Brighton Crop
Protection Conference—Pests and Diseases; British Crop
Protection Council: Farnham, UK, 1992; Vol. 1, p 29.
8. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J.
S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.;
Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier,
D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn,
J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.;
Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P.
C. J. Med. Chem. 1997, 40, 1347.
H NMR (CDCl
(s, 1H, H4), 2.22 (s, 3H, Me);
C NMR (CDCl , 100 MHz) d 168.2 (C6), 160.8 (C5),
3
3
, 400 MHz) d 7.43–7.25 (m, 5H, Ph), 6.35
1
3
160.0 (C3), 132.3–128.2 (Ph), 109.8 (C4), 84.8 (C7), 65.8
(C8), 18.9 (Me).
2
9 5 3
Compound 6a, C H Cl (M. wt 219.50); oil; CG-MS (EI
þ
70 eV) m=z (%): 218 (M , 43), 203 (100), 101 (57), 144 (36),
107 (19), 77 (17);
1
H NMR (CDCl
C NMR (CDCl
3
, 400 MHz) d 7.35–7.11 (5H, m, Ph);
, 100 MHz) d 132.0, 130.4, 128.3, 122.1
(Ph), 90.2 (C3), 86.7 (C2); 82.3 (C1).
Compound 6c, C (M. wt 213.54); oil; CG-MS (EI
1
3
3
8
H11Cl
3
þ
2
3
9. Linderman, R. J.; Lonicar, M. S. J. Org. Chem. 1988, 53,
70 eV) m=z (%): 213 (MH , 5), 141 (35), 129 (52), 95 (100),
71 (72);
6013.
1
0. Martins, M. A. P.; Beck, P.; Cunico, W.; Pereira, C. M. P.;
Sinhorin Blanco, R. F.; Peres; Bonacorso, H. G.; Zanatta,
N. Tetrahedron Lett. 2002, 43, 7005.
1. Compounds 2–8, were fully characterized by spectroscopy
methods, and satisfactory elemental analysis were ob-
tained: C ± 0.30, H ± 0.20; selected physical and spectral
data of the compounds 9, 10, are according to litera-
3
H NMR (CDCl , 400 MHz) d 2.41 (t, 2H, H4), 2.19 (m,
2H, H5), 1.58 (m, 2H, H6), 1.35 (m, 2H, H7), 0.89 (t, 3H,
H8);
1
3
3
C NMR (CDCl
(C3), 31.0 (C4), 27.1 (C5), 22.1 (C6), 18.7 (C7), 13.8 (C8).
3
, 100 MHz) d 93.4 (C1), 82.6 (C2), 69.6
Compound 7a, C
CG-MS (EI 70 eV) m=z (%): 136 (M , 100), 101 (43), 77
(38), 51 (29);
8
H
5
Cl (M. wt 136.58); bp 42 ꢁC/4 mbar;
þ
1
5c;17b;30
ture.
Compounds 2a,b and 3a did not show any IR bands on
the mOH region but presented mC@O at 1690, 1694 and
1
H NMR (CDCl
C NMR (CDCl
3
, 400 MHz) d 7.66–7.27 (5H, m, Ph);
, 100 MHz) d 132.9, 128.5, 128.3, 122.0
(Ph), 69.3 (C2), 67.3 (C1).
Compound 8a, C12 O (M. wt 224.18); oil; CG-MS (EI
1
3
3
ꢀ
1
1
697 cm , respectively.
Compound 2a, C10 Cl
2
H
5
3
O (M. wt 247.51); bp 120 ꢁC/
7 3
H F
þ
þ
.3 mbar; CG-MS (EI 70 eV) m=z (%): 246 (M , 10), 212
70 eV) m=z (%): 224 (M , 100), 155 (72), 102 (54), 77 (71),
51 (70);
(
2), 129 (100), 101 (90), 77 (99), 51 (90);
H NMR (CDCl
1
1
3
, 400 MHz) d 7.66–7.24 (m, 5H, Ph);
, 100 MHz) d 168.5 (C2), 133.6, 132.1,
28.8, 118.6 (Ph), 99.8 (C3), 95.3 (C1), 81.9 (C4).
H NMR (CDCl , 400 MHz) d 7.54–7.28 (m, 5H, Ph), 7.24
3
1
3
3
C NMR (CDCl
3
(d, 1H, H4,
3
J
H–H ¼ 16 Hz), 6.83 (d, 1H, H3,
100 MHz) 179.4 (C2, q,
1
J
C
J
H–H ¼ 16 Hz);
1
2
3
Compound 2b, C
4
HCl
3
O (M. wt 171.41); oil; CG-MS (EI
þ
NMR (CDCl
3
,
d
7
0 eV) m=z (%): 171 (MH , 5), 117 (100), 63 (85), 53 (20);
C–F ¼ 35 Hz), 132.8 (C3), 132.4–121.1 (Ph), 121.4 (C4),
1
1
H NMR (CDCl
3
, 400 MHz) d 2.09 (s, 1H, H4);
115.5 (C1, q, JC–F ¼ 289 Hz), 104.8 (C5), 87.1 (C6).